Clinical Trials Directory

Trials / Unknown

UnknownNCT05473754

Super: a Joint System in a Rehabilitation Educational Digital Platform

Feasibility Study About Super Digital Platform: a Joint System for Rehabilitation and Educational Projects for Children With Autism Spectrum Disorder

Status
Unknown
Phase
Study type
Observational
Enrollment
24 (estimated)
Sponsor
University of Milano Bicocca · Academic / Other
Sex
All
Age
3 Years – 7 Years
Healthy volunteers
Not accepted

Summary

Due to its complexity and variability, Autism Spectrum Disorder (ASD) requires multidisciplinary and multidimensional interventions. SUPER (in Italian: Sistema Unitario in una Piattaforma Riabilitativa ed Educativa) is an Italian digital platform, implemented to facilitate collaboration between families, health services, and schools and to promote personalized intervention for children with ASD. The research protocol, aimed to test SUPER's feasibility and usability, foresees the enrollment of 12 ASD children in the Experimental Group (EG) and 12 ASD children for the Control Group. All families, teachers, and clinicians will perform usual rehabilitative and educative interventions, but the EG will use SUPER, in addition to ordinary programs. The feasibility and acceptability of SUPER will be assessed through usability scales and questionnaires realized ad hoc for the purpose. At baseline and established endpoints, ASD patients will be evaluated with different assessment tools.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSUPER digital platformSUPER digital platform was implemented to ensure synergy between ASD families, health services, and schools through different tools to share rehabilitative and educational objectives and strategies. It was designed following the ASD International Guidelines and the recommendations of the ICF-CY and was organized into two areas: General (to promote scientific knowledge on ASD) and Personalized (restricted virtual space for groups of users following an individual with ASD).

Timeline

Start date
2022-05-09
Primary completion
2023-09-09
Completion
2024-04-30
First posted
2022-07-26
Last updated
2022-11-25

Locations

2 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT05473754. Inclusion in this directory is not an endorsement.